|
One RG7 4SW
|
|
("Cohort" or "the Company")
TOTAL VOTING RIGHTS
In accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1R, Cohort, the AIM listed independent technology group notifies the market that as at
The Company does not currently hold any Shares in treasury.
The above figure of 46,915,549 may be used by shareholders as the denominator in the calculations by which they may determine if they are required to notify their interest in, or a change to their interest in, the Company's Shares under the Disclosure Guidance and Transparency Rules.
ENDS
For further information please contact:
|
|
0118 909 0390 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
020 7597 5970 |
|
|
|
|
|
|
|
|
|
|
MHP |
07817 458804 |
|
|
|
||
NOTES TO EDITORS
Cohort (AIM: CHRT) was admitted to
The group is split into two segments - Communications and Intelligence, and Sensors and Effectors:
Communications and Intelligence
· EID designs and manufactures advanced communications systems for naval and military customers. Cohort acquired a majority stake in
· EM Solutions designs, assembles, tests, and supports satellite communications on-the-move terminals for defence and government customers. It also provides high-end broadband radio transceivers and other RF Subsystems such as low noise receivers and solid-state high-power transmitters for defence and commercial customers. Acquired by Cohort in
· MASS is a specialist data technology company serving the defence and security markets, focused on electronic warfare, digital services, and training support. Acquired by Cohort in
· MCL designs, sources, and supports advanced electronic and surveillance technology for
Sensors and Effectors
·
· ELAC SONAR supplies advanced sonar systems and underwater communications to global customers in the naval marketplace. Acquired by Cohort in
· SEA delivers and supports technology-based products for the defence and transport markets alongside specialist research and training services. Acquired by Cohort in
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the
